ATS-friendly plain text
AZIS R. DABAS, MBA · MS
Series A/B Healthtech GTM Operator | Provider Networks | Payer Strategy | AI-Enabled RevOps
New York, NY · 347.905.8582 · azis.rafael@gmail.com · linkedin.com/in/azis-dabas · azisdabas.com
EXECUTIVE VALUE PROPOSITION
Healthcare GTM and growth operator who turns provider demand, payer complexity, and fragmented care delivery into repeatable
revenue systems. Built provider networks, payer-aligned growth motions, AI-enabled RevOps, and care-navigation infrastructure across
PE-backed health systems, behavioral health, dialysis, and specialty pharmacy. Best fit: Series A/B healthtech companies moving from
founder-led traction to a disciplined commercial engine.
$8M+ ARR
Specialty pharmacy built from $0; 18%+ EBITDA;
strategic exit to Rite Aid
$125.9M
Referral and claims leakage identified via
Databricks claims forensics across 3B+ records
$13M+
Annualized referral revenue delivered across a 13-
facility NY dialysis network
1,200+
Clinicians onboarded in 90 days across psychiatry,
therapy, and addiction recovery
~4,000
Patients activated through referral, network, and
payer-aligned growth systems
$3.2M+
Value-based contracts across HEDIS/Stars, RAF/HCC,
AWV, and care-gap economics
FOUNDER / ZERO-TO-ONE OPERATING EXPERIENCE
Co-Founder & Operating Director | Nova Q Health & Viva Pharmacy · New York, NY 2019 - 2025
Specialty pharmacy platform spanning 340B, specialty therapeutics, compounding, payer/PBM contracting, compliance, patient access, and full P&L
ownership.
• Co-founded and scaled specialty pharmacy from $0 to $8M+ ARR; built operating model across licensing, compliance, payer contracting,
specialty workflows, inventory, dispensing operations, patient access, and provider partnerships.
• Orchestrated strategic exit to Rite Aid Corporation; led audit readiness, buyer diligence, integration planning, operational cleanup, data
preparation, compliance documentation, and negotiation support.
• Owned full P&L and maintained 18%+ EBITDA margins by optimizing payer/PBM contracts, drug mix, inventory controls, staffing model,
reimbursement accuracy, and operating throughput.
• Automated dispensing operations through ScriptPro robotics, increasing throughput 150% with 99.97% accuracy; secured URAC specialty
pharmacy accreditation and expanded complex therapy access to 5,000+ covered lives.
RECENT COMMERCIAL BUILDOUT MANDATES
Mandate-based growth roles focused on specific platform buildouts: provider acquisition, claims-intelligence, payer-aligned growth, AI RevOps, referral
architecture, and sales-to-implementation operating systems.
Executive Director, Growth & Partnerships | Mindful Care · New York, NY Oct 2025 - Mar 2026
Platform growth buildout for Sopris-backed same-day psychiatric urgent-care company operating hybrid in-person and telehealth care across six states.
• Owned growth strategy, provider network expansion, payer-aligned service-line commercialization, and AI-enabled commercial infrastructure
for a multi-state behavioral health platform.
• Onboarded 1,200+ clinicians in 90 days across psychiatry, therapy, and addiction recovery, expanding coverage 25% and improving same-day
access capacity.
• Built HubSpot RevOps and growth-intelligence infrastructure from zero: lifecycle taxonomy, multi-touch attribution, referral-source tagging,
predictive lead scoring, cohort segmentation, and LTV modeling.
• Reduced blended CAC 18%, increased patient lifetime value 3.2x, and generated $420K qualified pipeline in 60 days by prioritizing
reimbursement-aligned behavioral health service lines.
Director of Business Development | Doral Health & Wellness · New York, NY Apr 2025 - Oct 2025
PE-backed Article 28 multispecialty platform; value-creation mandate across network expansion, claims intelligence, M&A diligence, payer strategy, and
service-line commercialization.
• Built Databricks claims-intelligence framework across 3B+ claims records, surfacing $125.9M in referral and claims leakage across specialties
and payer segments.
• Established 1,362 net-new provider relationships across cardiology, endocrinology, nephrology, behavioral health, urology, and primary care
through referral mapping and specialty prioritization.
• Activated ~4,000 YTD patients and generated estimated $22M downstream lifetime value by converting referral relationships into measurable
patient volume, specialty utilization, and contribution margin.
• Negotiated $3.2M+ in value-based contracts tied to CMS-HCC V28, HEDIS/Stars, annual wellness visit capture, risk-adjustment specificity, care-
gap closure, and quality-bonus economics.
COMMERCIAL GROWTH & PROVIDER NETWORK LEADERSHIP
Director of Business Development | Atlantic Dialysis Management Services · New York, NY Oct 2024 - Apr 2025
Largest independent dialysis network in New York, operating 13 ESRD/CKD facilities in a complex payer, referral, and kidney-care policy environment.
• Delivered $13M+ in annualized referral revenue by redesigning nephrology referral architecture, expanding 40+ physician partnerships, and
building a system for relationship management, intake coordination, and conversion tracking.
• Increased acceptance rate 64%, reduced intake-to-treatment by 4.2 days, compressed referral cycle time 32%, and improved throughput 25%
across all 13 facilities through referral process redesign and operating cadence discipline.
• Guided transition through 2025 CMMI kidney-model overhaul, translating CKCC/KCC changes, KCF sunset dynamics, benchmark adjustments,
and QCP reductions into payer strategy and facility-level operating actions.
• Built payer-facing dashboards aligned to ESRD PPS and APG economics; supported operating conversations with Fidelis, Healthfirst, and
UnitedHealthcare.
Territory Leader & Enterprise Network Lead | Mega Aid Compounding Pharmacy · New York, NY 2018 - 2019
Institutional specialty pharmacy supporting hospital systems, multispecialty practices, post-acute providers, and complex-care integration.
• Expanded provider network to 2,000+ physicians and care sites across hospital systems, multispecialty practices, and post-acute environments;
created scalable and compliant onboarding engine across NYC metro market.
• Closed flagship Mount Sinai Health System partnership generating $2.3M+ annual revenue and creating a marquee enterprise reference
account that accelerated sales cycles.
• Built repeatable enterprise sales playbook for complex pharmacy partnerships: credentialing workflows, referral-source mapping, compliance
documentation, account onboarding, physician engagement, and operational handoff.
EARLIER COMMERCIAL FOUNDATION
Valeritas / V-Go Insulin Delivery - Inside Pharmaceutical Sales Representative (2016 - 2017): commercialized FDA-regulated insulin delivery product across
endocrinology and primary care; built foundation in provider-facing sales, reimbursement messaging, and chronic-disease commercialization.
Novo Nordisk / Saxenda & Victoza - Customer Care Manager / Health Coach (2015 - 2017): supported GLP-1 therapy engagement, patient adherence, HCP
communication, and chronic-disease education across obesity and diabetes care pathways.
QRO Call Center Operations - Director of Client Relations (2011 - 2016): led 100+ agents across 5+ regulated accounts with ownership of QA, compliance,
retention, escalation control, workforce discipline, and client communication.
OPERATING CAPABILITIES
GTM & Revenue Architecture
Provider network development; named-account strategy; territory design; pipeline
governance; service-line commercialization; strategic partnerships; patient
acquisition; expansion playbooks.
Payer & VBC Strategy
Medicare Advantage; Managed Medicaid; HEDIS/Stars; RAF/HCC; CMS-HCC V28;
CKCC/KCC; SSBCI; AWV/care-gap closure; total cost of care; payer contracting.
AI-Enabled RevOps & Analytics
Databricks; SQL; Python; claims forensics; HubSpot RevOps; AI-assisted scoring;
attribution; LTV/CAC; value-realization modeling; dashboard governance.
Healthcare AI & Workflow Design
AI-enabled RCM automation; prior authorization automation; denials intelligence;
claims/837 analytics; EHR/FHIR/API integration; care-navigation workflow design.
Founder / PE Operator
Full P&L; EBITDA; M&A diligence; board narratives; integration planning; exit
readiness; operating cadence; contribution-margin modeling.
Domain Breadth
Behavioral health; multispecialty care; ESRD/CKD; specialty pharmacy;
GLP-1/endocrinology; 340B/APG; Article 28/CON; URAC; regulated call-center
operations.
EDUCATION & SELECTED CREDENTIALS
MBA, Universidad Isabel I (2025) · M.S., Big Data & Business Intelligence, Universidad Isabel I (2025) · Business Administration Coursework, New York
University (2019 - 2023)
Selected credentials: Google Advanced Data Analytics · Google Business Intelligence · Johns Hopkins Health Informatics · Johns Hopkins Leading AI in
Healthcare · AAPC Certified Medical Biller · Certified Medical Office Manager · Advanced Valuation: M&A, PE & VC · Scrum Master Professional · SAS
Machine Learning Engineer Professional
Languages: English & Spanish (native) · French (advanced)